Variant report
Variant | esv3408790 |
---|---|
Chromosome Location | chr22:28999302-29001500 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:28996007..28999960-chr22:29194026..29197947,6 | MCF-7 | breast: | |
2 | chr22:28997050..28999545-chr22:28999902..29002703,2 | MCF-7 | breast: | |
3 | chr22:28997050..28999545-chr22:28999902..29002703,2 | MCF-7 | breast: | |
4 | chr22:29001462..29003738-chr22:29195242..29198224,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000100219 | chromatin interactions |
ENSG00000226471 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185190742 | chr22:28999322-28999323 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs538025629 | chr22:28999363-28999364 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs9613654 | chr22:28999369-28999370 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs554358871 | chr22:28999371-28999372 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs79755375 | chr22:28999374-28999375 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs139484975 | chr22:28999375-28999376 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs372822109 | chr22:28999382-28999383 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs5752763 | chr22:28999402-28999403 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs556822307 | chr22:28999490-28999491 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs578097602 | chr22:28999501-28999502 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs34323251 | chr22:28999524-28999525 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs553606630 | chr22:28999576-28999577 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs572060215 | chr22:28999633-28999634 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs542224307 | chr22:28999662-28999663 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs12166129 | chr22:28999668-28999669 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs5762712 | chr22:28999721-28999722 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs543291302 | chr22:28999725-28999726 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs564206055 | chr22:28999751-28999752 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs532224408 | chr22:28999755-28999756 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs576023071 | chr22:28999789-28999790 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs368676044 | chr22:28999790-28999791 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs541427795 | chr22:28999830-28999831 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs189226473 | chr22:28999850-28999851 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs374125895 | chr22:28999870-28999871 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs181924592 | chr22:28999878-28999879 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs12166245 | chr22:28999890-28999891 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs538571325 | chr22:28999900-28999901 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs540838260 | chr22:28999928-28999929 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs571880439 | chr22:28999935-28999936 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs538859303 | chr22:28999961-28999962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186814333 | chr22:28999987-28999988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536117716 | chr22:29000018-29000019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12166363 | chr22:29000057-29000058 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs542311929 | chr22:29000081-29000082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191594754 | chr22:29000082-29000083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570005833 | chr22:29000193-29000194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375751470 | chr22:29000214-29000215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183844762 | chr22:29000249-29000250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556762814 | chr22:29000286-29000287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575617536 | chr22:29000292-29000293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71275602 | chr22:29000310-29000311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186315440 | chr22:29000346-29000347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565055834 | chr22:29000370-29000371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190375869 | chr22:29000435-29000436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540880693 | chr22:29000441-29000442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559493723 | chr22:29000463-29000464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368240929 | chr22:29000484-29000485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs151223836 | chr22:29000587-29000588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577634925 | chr22:29000589-29000590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549480478 | chr22:29000671-29000672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
abnormal development | 18461090 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Cat eye syndrome | 16708226 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:28991400-29000800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr22:28991400-29001000 | Weak transcription | Fetal Lung | lung |
3 | chr22:28991400-29003600 | Weak transcription | NHLF | lung |
4 | chr22:28991400-29004200 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
5 | chr22:28991800-29007600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr22:28996200-29002800 | Weak transcription | Rectal Smooth Muscle | rectum |
7 | chr22:28997000-29000600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr22:28998200-29004000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr22:28999400-28999600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr22:28999800-29000000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr22:29000000-29000800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr22:29000600-29002000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr22:29000800-29001600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr22:29000800-29001600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr22:29000800-29001600 | Enhancers | HUVEC | blood vessel |
16 | chr22:29001000-29001400 | Enhancers | Brain Hippocampus Middle | brain |
17 | chr22:29001000-29001600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr22:29001000-29001600 | Enhancers | Fetal Lung | lung |
19 | chr22:29001000-29001800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr22:29001000-29001800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr22:29001200-29001600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
22 | chr22:29001200-29001600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |